Drug profile

The FDA adverse-event record for Gentamicin Spray

12 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Gentamicin Spray. See the species affected, top reactions, and outcomes below.

12
adverse-event reports
8.3%
death-coded share
Dog
most-reported species
3
Lack of efficacy - NOS - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
12
Total Reports
1
Deaths Reported
8.3%
Death Rate

Active Ingredients

Gentamicin Spray

Administration Routes

TopicalUnknown

Species Affected

Dog 10
Cat 2

Most Affected Breeds

Domestic Shorthair 2
Shepherd Dog - German 2
Terrier - Jack Russell 1
Bulldog - French 1
Siberian Husky 1
Dog (other) 1
Retriever - Golden 1
Pug 1
Retriever - Labrador 1
Shepherd Dog - Australian 1

Most Reported Reactions

Lack of efficacy - NOS 3
Application site pruritus 2
Polyuria 2
Polydipsia 2
Urinary incontinence 2
Deafness 1
Application site alopecia 1
Application site lesion 1
Application site erythema 1
Application site hair loss 1
Lethargy (see also Central nervous system depression in 'Neurological') 1
Appetite loss 1

Outcome Breakdown

Ongoing
7 (58.3%)
Outcome Unknown
2 (16.7%)
Recovered/Normal
2 (16.7%)
Died
1 (8.3%)

Gentamicin Spray Adverse Event Insights

12 reports name Gentamicin Spray; 1 recorded a death outcome (8.3% of reported events, not a population-level mortality rate). Active ingredient: Gentamicin Spray. Administration routes: Topical, Unknown.

By species: Dog (10 reports), Cat (2 reports). By breed: Domestic Shorthair (2), Shepherd Dog - German (2), Terrier - Jack Russell (1).

Leading clinical signs: Lack of efficacy - NOS (3), Application site pruritus (2), Polyuria (2), Polydipsia (2). Outcome, 12 coded reports: Ongoing leads at 58.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.